Earnings Ahead

KALV - KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc.

About

Profile


Headquarters

Massachusetts, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

KALV



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • KalVista Pharmaceuticals GAAP EPS of -$0.77
  • KalVista Pharmaceticals GAAP EPS of -$0.75 beats by $0.26
  • KalVista stock rises on regulatory guidance for hereditary angioedema therapy
  • AMRS, TTM and OMER among premarket gainers
  • KalVista stock rises ~20% on $58M stock, warrants offering
  • KalVista Pharmaceuticals GAAP EPS of -$0.90 beats by $0.16
  • KalVista's hereditary angioedema drug's orally disintegrating version shows promise in trial
  • KalVista Pharmaceuticals appoints Brian J.G. Pereira as Board Chairman
  • KalVista stock slumps 37% as KVD824 trial for hereditary angioedema ended over liver safety concerns
  • KalVista Pharmaceticals GAAP EPS of -$0.94
  • KalVista reaches five-month high as rival tumbles on hereditary angioedema
  • KalVista Pharmaceticals GAAP EPS of -$0.98 beats by $0.11
  • KalVista Pharmaceticals GAAP EPS of -$0.92 in-line
  • KalVista begins phase 3 trial of oral drug KVD900 to treat hereditary angioedema attacks
  • KalVista Pharmaceuticals grants inducement options to four new employees
  • KalVista Pharmaceuticals grants inducement options to four new employees
  • KalVista Pharmaceticals EPS misses by $0.01
  • KalVista Pharmaceuticals reports inducement grants to 6 new employees
  • KalVista to begin dosing in late-stage hereditary angioedema study early next year
  • KalVista announces lifting of clinical hold placed on hereditary angioedema study

Earnings History

Date EPS / Forecast Revenue / Forecast
December 9, 2021 -0.8 / -0.7914 - / -
September 13, 2021 - / -0.6 - / -
July 13, 2021 -0.65 / -0.532 - / -
March 11, 2021 -0.56 / -0.5957 - / -
December 10, 2020 -0.58 / -0.6714 - / -
September 14, 2020 -0.61 / -0.6 - / 1.5M
July 13, 2020 - / -0.65 - / 1.95M
July 1, 2020 -0.37 / -0.65 3.82M / 1.9M Beat!
March 10, 2020 -0.52 / -0.26 1.58M / 10.08M
December 3, 2019 -0.33 / -0.55 3.92M / 3.27M Beat!
September 9, 2019 -0.42 / -0.62 3.37M / 3.22M Beat!
July 15, 2019 -0.49 / -0.35 2.93M / 4.03M
March 14, 2019 -0.23 / -0.45 3.89M / 4.25M
December 14, 2018 -0.22 / -0.46 5.59M / 3.74M Beat!
September 14, 2018 -0.47 / -0.33 3.72M / 3.81M
July 31, 2018 -0.06 / -0.26 4.84M / 5M
March 14, 2018 - / -0.13 - / 5.40M
March 28, 2017 - / -0.6 - / -
November 9, 2016 - / - 7.00K / - Beat!
August 16, 2016 - / - 7.00K / - Beat!
May 24, 2016 -0.25 / -0.2 7.00K / - Beat!
March 16, 2016 -0.23 / -0.2 8.00K / - Beat!
Date Price Open High Low Vol Change ER
May 26, 2023 9.48 9.76
9.86
9.03
247K -2.87%
May 25, 2023 9.76 10.39
10.57
9.74
155K -5.97%
May 24, 2023 10.38 10.5
10.67
10.33
221K -1.8%
May 23, 2023 10.57 10.57
10.95
10.55
166K 0%
May 22, 2023 10.57 10.41
10.61
10.1
324K 0.38%
 
May 19, 2023 10.53 10.47
10.76
10.46
159K 1.25%
May 18, 2023 10.4 10.27
10.43
9.99
487K 1.07%
May 17, 2023 10.29 10.13
10.4
9.93
229K 2.39%
May 16, 2023 10.05 10.08
10.16
9.89
230K -0.59%
May 15, 2023 10.11 9.7
10.35
9.33
156K 3.27%
May 12, 2023 9.79 9.79
9.83
9.62
104K 0.62%
May 11, 2023 9.73 9.58
9.77
9.45
104K 0%
May 10, 2023 9.73 9.57
9.88
9.21
187K 3.29%
May 9, 2023 9.42 9.47
9.55
9.35
87.5K -1.26%
May 8, 2023 9.54 9.49
9.65
9.36
304K -0.83%
May 5, 2023 9.62 9.45
9.65
9.45
164K 3%
May 4, 2023 9.34 9.18
9.44
9.1
142K 1.85%
May 3, 2023 9.17 8.91
9.36
8.82
662K 3.03%
May 2, 2023 8.9 8.86
9
8.82
209K 0.34%
May 1, 2023 8.87 8.53
8.97
8.39
289K 3.99%
Apr 28, 2023 8.53 8.33
8.69
8.33
179K 2.03%
Apr 27, 2023 8.36 8.03
8.53
7.94
125K 4.50%
Apr 26, 2023 8 8.02
8.08
7.88
393K -0.62%
Apr 25, 2023 8.05 7.97
8.26
7.97
131K 0.37%
Apr 24, 2023 8.02 8.21
8.25
7.97
106K -2.2%
Apr 21, 2023 8.2 8.14
8.29
8
164K 0.49%
Apr 20, 2023 8.16 8.18
8.25
8.07
71.5K -0.73%
Apr 19, 2023 8.22 7.87
8.25
7.77
164K 4.05%
Apr 18, 2023 7.9 8.03
8.07
7.75
438K -1.99%
Apr 17, 2023 8.06 7.96
8.37
7.91
492K 1.90%
Apr 14, 2023 7.91 8.16
8.16
7.63
187K -2.83%
Apr 13, 2023 8.14 8.01
8.35
7.81
168K 2.01%
Apr 12, 2023 7.98 8.53
8.53
7.92
175K -5.79%
Apr 11, 2023 8.47 8.21
8.5
8.04
169K 3.42%
Apr 10, 2023 8.19 7.96
8.19
7.67
257K 2.63%
Apr 6, 2023 7.98 7.7
8.09
7.53
229K 3.23%
Apr 5, 2023 7.73 8
8.03
7.63
211K -3.62%
Apr 4, 2023 8.02 8.23
8.27
7.84
170K -2.2%
Apr 3, 2023 8.2 7.88
8.2
7.87
429K 4.33%
Mar 31, 2023 7.86 7.58
7.92
7.45
512K 4.38%
Mar 30, 2023 7.53 7.47
7.63
7.33
224K 1.07%
Mar 29, 2023 7.45 6.83
7.46
6.83
409K 9.40%
Mar 28, 2023 6.81 6.63
6.92
6.6
118K 3.03%
Mar 27, 2023 6.61 6.55
6.8
6.5
180K 1.54%
Mar 24, 2023 6.51 6.43
6.58
6.29
114K 0.15%
Mar 23, 2023 6.5 6.36
6.66
6.31
300K 3.17%
Mar 22, 2023 6.3 7.08
7.08
6.26
415K -11.02%
Mar 21, 2023 7.08 7.16
7.16
6.91
304K 0.85%
Mar 20, 2023 7.02 7.37
7.37
6.75
399K -5.01%
Mar 17, 2023 7.39 7.34
7.49
7.2
425K -0.81%
Mar 16, 2023 7.45 7.39
7.56
7.24
298K 0%
Mar 15, 2023 7.45 7.56
7.68
7.25
256K -2.87%
Mar 14, 2023 7.67 7.61
7.79
7.37
331K 2.40%
Mar 13, 2023 7.49 6.89
7.64
6.89
201K 7.61%
Mar 10, 2023 6.96 7.49
7.49
6.58
519K -5.31%
Mar 9, 2023 7.35 7.87
8.27
7.3
375K -5.41%
Mar 8, 2023 7.77 7.63
7.8
7.44
165K 1.17%
Mar 7, 2023 7.68 7.6
7.93
7.59
145K 0.39%
Mar 6, 2023 7.65 8.15
8.16
7.59
197K -6.36%
Mar 3, 2023 8.17 7.9
8.31
7.62
272K 0%